Previous 10 | Next 10 |
MORRISVILLE, N.C., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Chief Executive Officer Alistair Macdonald and Chief Financial Officer Jason Meggs are scheduled to present a...
Image source: The Motley Fool. Syneos Health, inc (NASDAQ: SYNH) Q2 2021 Earnings Call Aug 9, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Syneos Health, inc (SYNH) Q2 2021 Earnings Call Transcript
The following slide deck was published by Syneos Health, Inc. in conjunction with their 2021 Q2 earnings call. For further details see: Syneos Health, Inc. 2021 Q2 - Results - Earnings Call Presentation
Syneos Health, Inc. (SYNH) Q2 2021 Earnings Conference Call August 9, 2021 08:00 ET Company Participants Ronnie Speight - Senior Vice President, Investor Relations Alistair Macdonald - Chief Executive Officer Jason Meggs - Chief Financial Officer Michelle Keefe - President, Commercial Solutio...
Highlights Second quarter revenue of $1,282.6 million, increased 6.1% sequentially and 26.6% year-over-year. Clinical Solutions net new business awards of $1,436.2 million for the second quarter, representing year-over-year growth of 21.2% and a book-to-bill ratio of 1.45x, ...
AMRX,APD,AVYA,BALY,BHVN,BLUE,BNTX,CEVA,CRNC,DISH,EBIX,ELAN,ENR,EPZM,GOLD,GTES,KOD,RDNT,SGMS,SWAV,SYNH,TGNA,TSN,TTD,USFD,VTRS,VTR For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Monday's open
Syneos Health and Aetion Partner to Offer RWE Solutions to Advance Drug Development and Commercialization Partnership will enable biopharma companies to accelerate clinical development, market access, and the uptake of new therapies PR Newswire MORRISVILLE, N.C. ...
ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy took a pause as some of our best performing ...
MORRISVILLE, N.C., July 14, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the appointment of Michael Brooks to the newly created role of Chief Development Officer. In this role, Brooks wil...
MORRISVILLE, N.C., July 12, 2021 (GLOBE NEWSWIRE) -- Syneos Health ® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its second quarter 2021 financial results on Monday, August 9, 2021, prior to its earnings call at 8:00 a.m. ET. ...
News, Short Squeeze, Breakout and More Instantly...
Mitsubishi Tanabe Pharma America Celebrates Eight-Year Anniversary in the U.S. PR Newswire JERSEY CITY, N.J. , April 29, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc. (MTPA) is celebrating its eight-year anniversary of being established in th...
Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting PR Newswire Presentations span Parkinson's disease and ALS clinical and real-world evidence Oral platform sessions will highlight r...
Mitsubishi Tanabe Pharma America Receives U.S. Food and Drug Administration Orphan Drug Exclusivity for RADICAVA ORS® (edaravone) PR Newswire Orphan Drug Exclusivity recognized for RADICAVA ORS based on major contribution to patient care JERSEY CITY, N.J. ...